Anti-TREM2 antibodies and related methods
US11505602B2 · kind B2 · utility
0Cited by
6References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2019 |
| Grant date | Nov 22, 2022 |
| Priority date | — |
| Expiry date | Jul 20, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.